Oldenburg Michael S, Frisch Christopher D, Lindor Noralane M, Edell Eric S, Kasperbauer Jan L, O'Brien Erin K
Department of Otorhinolaryngology, Mayo Clinic School of Medicine, 200 First St SW, Rochester, MN.
Department of Otorhinolaryngology, Mayo Clinic School of Medicine, 200 First St SW, Rochester, MN.
Am J Otolaryngol. 2015 Sep-Oct;36(5):636-41. doi: 10.1016/j.amjoto.2015.04.005. Epub 2015 Apr 15.
Myhre-LAPS syndrome is a recently recognized disease caused by a mutation in the SMAD4 gene. This results in a range of pathology including laryngotracheal stenosis, arthropathy, prognathism and short stature, or LAPS syndrome. We aim to delineate the role of intubation in development of airway stenosis in these patients as well as provide insight into diagnosis and management of this syndrome. Herein we present four patients with Myhre-LAPS syndrome complicated by airway stenosis and perform a systematic review of all cases of Myhre-LAPS syndrome with reported airway pathology.
Retrospective review
All patients diagnosed with Myhre-LAPS syndrome and airway stenosis at a single institution from 1981 to 2014 were reviewed.
Four patients (4F, median age 42) were identified that met inclusion criteria. Initial presenting signs included progressive shortness of breath, dyspnea on exertion and respiratory distress. All four (100%) patients had multi-level airway stenosis most commonly in the subglottic and glottic regions and all patients had undergone at least one endotracheal intubation prior to presentation. One patient with a history of nasal tracheal intubation presented with nasal obstruction and was found to have choanal as well as subglottic stenosis. Two of the four (50%) patients are tracheostomy tube dependent, 1/4 (25%) died of a fatal cardiac arrhythmia and 1/4 (25%) has had 6 endoscopic treatments for subglottic stenosis in 4 years with rapid symptom recurrence.
Myhre-LAPS syndrome is characterized by progressive systemic fibrosis and patients are diagnosed by characteristic findings of prognathism, short stature, abnormal facies, and thick skin among other abnormalities. Airway management is complicated by recurrent, refractory subglottic stenosis often preceded by elective intubation as well as maxillary hypoplasia, trismus, and limited neck extension. Endotracheal intubation and surgical intervention should be approached with caution in these patients and multidisciplinary care teams are necessary to address all manifestations of this syndrome.
Myhre-LAPS综合征是一种最近才被认识的由SMAD4基因突变引起的疾病。这会导致一系列病理表现,包括喉气管狭窄、关节病、凸颌和身材矮小,即LAPS综合征。我们旨在阐明插管在这些患者气道狭窄发展中的作用,并深入了解该综合征的诊断和管理。在此,我们报告4例合并气道狭窄的Myhre-LAPS综合征患者,并对所有报道有气道病变的Myhre-LAPS综合征病例进行系统回顾。
回顾性研究
对1981年至2014年在单一机构诊断为Myhre-LAPS综合征和气道狭窄的所有患者进行回顾。
确定了4例符合纳入标准的患者(4名女性,中位年龄42岁)。最初的表现包括进行性气短、劳力性呼吸困难和呼吸窘迫。所有4例(100%)患者均有多节段气道狭窄,最常见于声门下和声门区域,且所有患者在就诊前均至少接受过一次气管插管。1例有鼻气管插管史的患者出现鼻塞,发现有后鼻孔和声门下狭窄。4例患者中有2例(50%)依赖气管造口管,1/4(25%)死于致命性心律失常,1/4(25%)在4年内因声门下狭窄接受了6次内镜治疗,但症状迅速复发。
Myhre-LAPS综合征的特征是进行性全身纤维化,患者通过凸颌、身材矮小、面容异常和皮肤增厚等特征性表现得以诊断。气道管理因反复出现的难治性声门下狭窄而变得复杂,这种狭窄通常在择期插管之前出现,同时还伴有上颌骨发育不全、牙关紧闭和颈部伸展受限。对于这些患者,气管插管和手术干预应谨慎进行,需要多学科护理团队来处理该综合征的所有表现。